Teddy J. Wohlbold

Pediatrics
600 East 233rd Street
New York, NY 10466

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19.

SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19.

Journal: The Journal of experimental medicine
Published: September 01, 2022

Broadly protective human antibodies that target the active site of influenza virus neuraminidase.

Broadly protective human antibodies that target the active site of influenza virus neuraminidase.

Journal: Science (New York, N.Y.)
Published: May 16, 2019

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.

Journal: The Lancet. Infectious diseases
Published: March 27, 2019

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.

Journal: Journal of virology
Published: September 25, 2018

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine.

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine.

Journal: Science immunology
Published: May 24, 2018

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

Journal: PloS one
Published: January 02, 2018

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.

Journal: Cell
Published: December 13, 2017

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies.

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies.

Journal: Journal of visualized experiments : JoVE
Published: September 06, 2017

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

Journal: Journal of virology
Published: April 17, 2017

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.

Journal: NPJ vaccines
Published: April 04, 2017

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

Journal: Nature microbiology
Published: March 11, 2017

A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.

A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.

Journal: Antiviral research
Published: January 21, 2017
Showing 1-12 of 21

Last Updated: 09/26/2026